Navigation Links
Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
Date:10/25/2012

ing approximately 2.1 million lives in New York and New Jersey, and ConnectiCare, covering approximately 228,000 lives in Connecticut.

"In addition to continued expansion of reimbursement, we have had further positive clinical data released on Urgent PC.  The 3-year STEP Study data was presented for the first time at the Western Section American Urological Association conference in Hawaii earlier this month. This multi-center study demonstrated that patients who respond to the initial 12 weeks of Urgent PC therapy sustained their symptom improvement over 3 years," said Mr. Kaysen.

Macroplastique sales in the U.S. totaled $1.4 million in the fiscal second quarter, up 4% over the same quarter last year. "Over the past year, we have successfully built our share in the bulking market and during fiscal 2013 we anticipate steady sales from Macroplastique," Mr. Kaysen commented.

Net sales to customers outside of the U.S. for the fiscal second quarter totaled $1.5 million, a decrease of 3% from the prior fiscal year's second quarter.  Excluding the impact of fluctuations in foreign currency exchange rates, total sales outside the U.S. were up 6%.  Urgent PC sales outside of the U.S. of $510,000 increased 31% from $389,000 in the prior fiscal year's second quarter. Excluding the impact of fluctuations in foreign currency exchange rates, Urgent PC sales increased 40%.

The Company reported an operating loss of $642,000 in the fiscal second quarter, compared with a $1.3 million operating loss in the same quarter last year. Excluding non-cash charges for share-based compensation and depreciation and amortization expense, the non-GAAP operating loss was $163,000 in the second quarter of fiscal 2013, compared with an $837,000 non-GAAP operating loss in the second quarter a year ago.  The decrease in operating loss was primarily attributable to the increase in sales and improved gross margin, which more than offset the increase in ope
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Uroplasty To Participate In Two Upcoming Conferences
2. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
3. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
4. Uroplasty To Present At The JMP Securities Healthcare Conference
5. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
6. Uroplasty Announces Product Development and New Clinical Trial Initiatives
7. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
8. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2012
9. Zimmer Holdings, Inc. Reports Third Quarter 2012 Financial Results
10. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
11. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the ... detection of pathogenic bacteria, including potential bioterrorism agents ... Bacillus anthracis which feature on the Center ... bio-threats. This seminal study, conducted in collaboration with ... Salisbury (DSTL), United Kingdom ...
(Date:5/20/2013)... YORK , May 20, 2013  Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence.  The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... Mai 2013 Sequent Medical, Inc. ... CE-Kennzeichnung für die SL-Produktfamilie („Single Layer") seiner ... hat. Das Unternehmen hat in ausgewählten neurovaskulären ... Einführung dieser neuen Modelle begonnen. Neben einem ... verbessertes Handling, das es Ärzten ermöglicht, ein ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3
... Dec. 16, 2010 Watson Pharmaceuticals, Inc. (NYSE: ... today announced that Watson,s subsidiary, Watson Laboratories, Inc. has ... ("Preglem") the wholly owned subsidiary of Richter, to develop ... Canada.  In European studies, Esmya™ has been shown to ...
... announced today the award recipients from its November Virtual ... March of Dimes, National Prematurity Awareness Month. This year ... Neonatal Intensive Care Unit. In addition, the number of ... six in 2010.  Each of the following hospitals will ...
Cached Medicine Technology:Watson and Richter Announce Exclusive License Agreement for Esmya™ 2Watson and Richter Announce Exclusive License Agreement for Esmya™ 3Watson and Richter Announce Exclusive License Agreement for Esmya™ 4Watson and Richter Announce Exclusive License Agreement for Esmya™ 5Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2010 Prematurity Awareness Month 2
(Date:5/20/2013)... May 20, 2013 Fastcare Miami Beach ... infection (UTI) within its first symptoms, as if not treated, ... a more serious infection. Although a urinary tract infection in ... lead to serious kidney infection called pyelonephritis. Women seem to ... come up to the same percentage as women after the ...
(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... been released to the public creating a frenzy ... access to this elite business training. WealthSpringMarketing.com's Tiffany ... as well as an exclusive bonus. , "Eben ... providing elite business training to individuals serious about ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Parker Waichman ... rights of victims injured by defective drugs, has filed ... who alleges that use of the diabetes drug medication ... was filed on April 30, 2013, in the U.S. ... No. 6:13-cv-0888), where it is one of thousands of ...
(Date:5/20/2013)... Leading facial plastic surgeon and ENT specialist Dr. ... Doc” in the field of Otolaryngology in the May/June 2013 ... Beacher magazine, one of Palm Beach County’s leading lifestyle publications, ... 2013 issue, including 70 of the very best physicians in ... to do, health and fitness, people to watch, top doctors, ...
Breaking Medicine News(10 mins):Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
... meditation training are associated with greater telomerase activity, according ... the University of California, San Francisco. The study is ... an enzyme important for the long-term health of cells ... attributable to psychological changes that increase a person,s ability ...
... Nov. 3 Stereotactic body radiotherapy (SBRT), a radiation ... Institute (UPCI) that precisely delivers a large dose of ... and neck cancers when combined with the chemotherapy Cetuximab, ... research will be presented today at the American Society ...
... suggests that older adults who wear multifocal contact lenses ... condition that increases with age, may have greater difficulty ... Age-related problems with near vision, medically termed presbyopia, usually ... the inability to focus on objects up close. ...
... HealthDay Reporter , WEDNESDAY, Nov. 3 (HealthDay News) -- ... between asthma and lung cancer in a small study. ... pulmonary disease (COPD) and lung cancer, but this is the ... and lung cancer, the researchers said. However, based on ...
... professionals, has been selected to serve as a partner ... beginning Sept. 21, 2010. A coalition of 48 ... reconstitute the NPP, which currently comprises 32 organizations working ... The NPP,s previous work has targeted ways to eliminate ...
... Calif., Nov. 3, 2010 The U.S. Department of Veterans ... scientist the highest honor it bestows on scientists. ... Department of Orthopaedic Surgery, will receive $1.4 million to support ... Beach VA Medical Center. "Dr. Lee is one of ...
Cached Medicine News:Health News:Positive psychological changes from meditation training linked to cellular health 2Health News:Positive psychological changes from meditation training linked to cellular health 3Health News:Combining radiation therapy, chemotherapy safely treats head and neck cancer patients 2Health News:Multifocal contact lenses may reduce vision for night driving 2Health News: Asthma Linked to Lung Cancer Risk in Study 2Health News:National Quality Forum picks AMIA for national priorities partnership 2Health News:VA names UCI orthopedic biomedical engineer a senior research career scientist 2
TC-98 elisa strip reader. Reads, calculates, and prints results for up to 12 wells in about 30 seconds. Single point calibration. Multi-point calibration....
... Personal Plate Shaker with Timer are designed ... of 96 & 384-well microplates. The on/off button, ... located on the side of the unit. The ... the unit for adjustment of speed from a ...
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
... flow cytometer for all applications in Cytomics ... absolute counting. The CyFlow ML allows to ... signals in combination with up to 13 ... can perform in a wide variety of ...
Medicine Products: